Lars Bastholt


Ontology type: schema:Person     


Person Info

NAME

Lars

SURNAME

Bastholt

Publications in SciGraph latest 50 shown

  • 2018-12 Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form in HEALTH AND QUALITY OF LIFE OUTCOMES
  • 2016-12 The role of FDG-PET/CT in preoperative staging of sentinel lymph node biopsy-positive melanoma patients in EJNMMI RESEARCH
  • 2015-06 Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2015-03 Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanoma in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2015-02 Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2012-08 La pre-stimolazione con TSH umano ricombinante migliora il risultato a lungo termine della terapia con radioiodio del gozzo multinodulare non tossico in L'ENDOCRINOLOGO
  • 2012-02 CHEK2*1100delC and Risk of Malignant Melanoma: Danish and German Studies and Meta-Analysis in JOURNAL OF INVESTIGATIVE DERMATOLOGY
  • 2011-12 A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2008-12 Motesanib difosfato nel cancro tiroideo differenziato progressivo in L'ENDOCRINOLOGO
  • 2005-08 Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model in BRITISH JOURNAL OF CANCER
  • 2000-05 Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer; A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age in BREAST CANCER RESEARCH AND TREATMENT
  • 1994-09 The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1994-01 The pharmacokinetics of high-dose epirubicin and of the cardioprotector ADR-529 given together with cyclophosphamide, 5-fluorouracil, and tamoxifen in metastatic breast-cancer patients in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1991-11 A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1991-05 A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1991-01 Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1989-06 Pharmacokinetics of oral idarubicin in breast cancer patients with reference to antitumor activity and side effects in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.7143.1", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5842.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.475435.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10825.3e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.9024.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417144.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410345.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415302.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5395.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417893.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417886.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412004.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4973.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.477052.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418116.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418165.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7942.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.34477.33", 
            "type": "Organization"
          }
        ], 
        "familyName": "Bastholt", 
        "givenName": "Lars", 
        "id": "sg:person.01322567407.20", 
        "identifier": {
          "name": "orcid_id", 
          "type": "PropertyValue", 
          "value": [
            "0000-0001-5478-9826"
          ]
        }, 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322567407.20", 
          "https://orcid.org/0000-0001-5478-9826"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:32", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_279.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01322567407.20'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01322567407.20'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01322567407.20'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01322567407.20'


     

    This table displays all metadata directly associated to this object as RDF triples.

    59 TRIPLES      11 PREDICATES      32 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01322567407.20 schema:affiliation N3069f6d8d0814e2a98401fc4bdebe53e
    2 https://www.grid.ac/institutes/grid.10825.3e
    3 https://www.grid.ac/institutes/grid.240145.6
    4 https://www.grid.ac/institutes/grid.34477.33
    5 https://www.grid.ac/institutes/grid.410345.7
    6 https://www.grid.ac/institutes/grid.412004.3
    7 https://www.grid.ac/institutes/grid.415302.1
    8 https://www.grid.ac/institutes/grid.417144.3
    9 https://www.grid.ac/institutes/grid.417886.4
    10 https://www.grid.ac/institutes/grid.417893.0
    11 https://www.grid.ac/institutes/grid.418116.b
    12 https://www.grid.ac/institutes/grid.418165.f
    13 https://www.grid.ac/institutes/grid.475435.4
    14 https://www.grid.ac/institutes/grid.477052.3
    15 https://www.grid.ac/institutes/grid.4973.9
    16 https://www.grid.ac/institutes/grid.5395.a
    17 https://www.grid.ac/institutes/grid.5842.b
    18 https://www.grid.ac/institutes/grid.65499.37
    19 https://www.grid.ac/institutes/grid.7942.8
    20 https://www.grid.ac/institutes/grid.9024.f
    21 schema:familyName Bastholt
    22 schema:givenName Lars
    23 schema:identifier Na319a058d2cb43ddbc4d087c7c7a53c4
    24 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322567407.20
    25 https://orcid.org/0000-0001-5478-9826
    26 schema:sdDatePublished 2019-03-07T14:32
    27 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    28 schema:sdPublisher N8f1ac40d2b9645438d0b8fb6ad55fa16
    29 sgo:license sg:explorer/license/
    30 sgo:sdDataset persons
    31 rdf:type schema:Person
    32 N3069f6d8d0814e2a98401fc4bdebe53e schema:affiliation https://www.grid.ac/institutes/grid.7143.1
    33 sgo:isCurrent true
    34 rdf:type schema:OrganizationRole
    35 N8f1ac40d2b9645438d0b8fb6ad55fa16 schema:name Springer Nature - SN SciGraph project
    36 rdf:type schema:Organization
    37 Na319a058d2cb43ddbc4d087c7c7a53c4 schema:name orcid_id
    38 schema:value 0000-0001-5478-9826
    39 rdf:type schema:PropertyValue
    40 https://www.grid.ac/institutes/grid.10825.3e schema:Organization
    41 https://www.grid.ac/institutes/grid.240145.6 schema:Organization
    42 https://www.grid.ac/institutes/grid.34477.33 schema:Organization
    43 https://www.grid.ac/institutes/grid.410345.7 schema:Organization
    44 https://www.grid.ac/institutes/grid.412004.3 schema:Organization
    45 https://www.grid.ac/institutes/grid.415302.1 schema:Organization
    46 https://www.grid.ac/institutes/grid.417144.3 schema:Organization
    47 https://www.grid.ac/institutes/grid.417886.4 schema:Organization
    48 https://www.grid.ac/institutes/grid.417893.0 schema:Organization
    49 https://www.grid.ac/institutes/grid.418116.b schema:Organization
    50 https://www.grid.ac/institutes/grid.418165.f schema:Organization
    51 https://www.grid.ac/institutes/grid.475435.4 schema:Organization
    52 https://www.grid.ac/institutes/grid.477052.3 schema:Organization
    53 https://www.grid.ac/institutes/grid.4973.9 schema:Organization
    54 https://www.grid.ac/institutes/grid.5395.a schema:Organization
    55 https://www.grid.ac/institutes/grid.5842.b schema:Organization
    56 https://www.grid.ac/institutes/grid.65499.37 schema:Organization
    57 https://www.grid.ac/institutes/grid.7143.1 schema:Organization
    58 https://www.grid.ac/institutes/grid.7942.8 schema:Organization
    59 https://www.grid.ac/institutes/grid.9024.f schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...